Fulgent Genetics, Inc. - COM (FLGT)

Historical Portfolio Holders from Q3 2016 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
16.1M
Holdings value Q3 2024
$350M
Value change Q3 2024
+$18.6M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
181
Number of buys Q3 2024
75
Number of sells Q3 2024
-81
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 16.1M $350M +$18.6M $21.73 182
2024 Q2 15.3M $300M +$11.5M $19.62 170
2024 Q1 14.6M $317M +$2.9M $21.70 176
2023 Q4 14.3M $413M +$10.6M $28.91 190
2023 Q3 14M $375M -$367K $26.74 195
2023 Q2 13.9M $515M +$13.6M $37.03 210
2023 Q1 13.5M $423M +$14.3M $31.22 214
2022 Q4 13.1M $391M -$9.33M $29.78 215
2022 Q3 13.3M $506M -$7.91M $38.12 215
2022 Q2 13M $709M +$53.9M $54.53 250
2022 Q1 12M $752M +$40.4M $62.41 265
2021 Q4 11.2M $1.13B -$26.3M $100.59 287
2021 Q3 11.4M $1.02B +$64.8M $89.95 258
2021 Q2 10.6M $980M +$54.3M $92.23 249
2021 Q1 10M $966M +$65M $96.62 242
2020 Q4 9.61M $501M +$82.2M $52.10 182
2020 Q3 8.08M $324M +$79.8M $40.04 121
2020 Q2 6.32M $101M +$14.6M $16.00 78
2020 Q1 6.11M $65.5M +$3.54M $10.76 70
2019 Q4 5.66M $73M +$35.3M $12.90 68
2019 Q3 2.93M $30.4M +$16.9M $10.39 32
2019 Q2 1.3M $8.69M +$411K $6.68 12
2019 Q1 1.24M $7.39M +$221K $5.95 15
2018 Q4 1.21M $3.84M -$983K $3.17 13
2018 Q3 1.46M $5.73M +$22.5K $3.93 15
2018 Q2 1.45M $6.01M +$11.6K $4.14 15
2018 Q1 1.45M $5.79M +$113K $3.99 18
2017 Q4 1.42M $6.2M -$6.55M $4.38 16
2017 Q3 2.39M $11.4M -$4.07M $4.78 18
2017 Q2 2.98M $19M -$5.82M $6.39 20
2017 Q1 3.49M $38.1M +$4.85M $10.92 35
2016 Q4 3.07M $35.5M +$8.32M $11.57 37
2016 Q3 2.65M $21.8M +$21.8M $9.22 16